Literature DB >> 24098055

TGF-β: guardian of T cell function.

Soyoung A Oh1, Ming O Li.   

Abstract

A fundamental aspect of the adaptive immune system is the generation and maintenance of a diverse and self-tolerant T cell repertoire. Through its regulation of T cell development, homeostasis, tolerance, and differentiation, the highly evolutionarily conserved cytokine TGF-β critically supports a functional T cell pool. The pleiotropic nature of this regulation is likely due to the elaborate control of TGF-β production and activation in the immune system, and the intricacy of TGF-β signaling pathways. In this review we discuss the current understanding of TGF-β regulation of T cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24098055      PMCID: PMC3856438          DOI: 10.4049/jimmunol.1301843

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  76 in total

1.  T cell surveillance of oncogene-induced prostate cancer is impeded by T cell-derived TGF-β1 cytokine.

Authors:  Moses K Donkor; Abira Sarkar; Peter A Savage; Ruth A Franklin; Linda K Johnson; Achim A Jungbluth; James P Allison; Ming O Li
Journal:  Immunity       Date:  2011-07-14       Impact factor: 31.745

2.  TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology.

Authors:  Mandy J McGeachy; Kristian S Bak-Jensen; Yi Chen; Cristina M Tato; Wendy Blumenschein; Terrill McClanahan; Daniel J Cua
Journal:  Nat Immunol       Date:  2007-11-11       Impact factor: 25.606

3.  T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation.

Authors:  Ming O Li; Yisong Y Wan; Richard A Flavell
Journal:  Immunity       Date:  2007-05-03       Impact factor: 31.745

4.  Cell-intrinsic abrogation of TGF-β signaling delays but does not prevent dysfunction of self/tumor-specific CD8 T cells in a murine model of autochthonous prostate cancer.

Authors:  Cassie K Chou; Andrea Schietinger; H Denny Liggitt; Xiaoxia Tan; Sarah Funk; Gordon J Freeman; Timothy L Ratliff; Norman M Greenberg; Philip D Greenberg
Journal:  J Immunol       Date:  2012-09-14       Impact factor: 5.422

5.  Clonal deletion and the fate of autoreactive thymocytes that survive negative selection.

Authors:  Leonid A Pobezinsky; Georgi S Angelov; Xuguang Tai; Susanna Jeurling; François Van Laethem; Lionel Feigenbaum; Jung-Hyun Park; Alfred Singer
Journal:  Nat Immunol       Date:  2012-04-29       Impact factor: 25.606

6.  T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse.

Authors:  Amy E Moran; Keli L Holzapfel; Yan Xing; Nicole R Cunningham; Jonathan S Maltzman; Jennifer Punt; Kristin A Hogquist
Journal:  J Exp Med       Date:  2011-05-23       Impact factor: 14.307

7.  iNKT cell development is orchestrated by different branches of TGF-beta signaling.

Authors:  Jean-Marc Doisne; Laurent Bartholin; Kai-Ping Yan; Céline N Garcia; Nadia Duarte; Jean-Benoît Le Luduec; David Vincent; Farhan Cyprian; Branka Horvat; Sylvie Martel; Ruth Rimokh; Régine Losson; Kamel Benlagha; Julien C Marie
Journal:  J Exp Med       Date:  2009-05-18       Impact factor: 14.307

8.  TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function.

Authors:  Liang Zhou; Jared E Lopes; Mark M W Chong; Ivaylo I Ivanov; Roy Min; Gabriel D Victora; Yuelei Shen; Jianguang Du; Yuri P Rubtsov; Alexander Y Rudensky; Steven F Ziegler; Dan R Littman
Journal:  Nature       Date:  2008-03-26       Impact factor: 49.962

9.  Truncated form of TGF-βRII, but not its absence, induces memory CD8+ T cell expansion and lymphoproliferative disorder in mice.

Authors:  Harumichi Ishigame; Munir M Mosaheb; Shomyseh Sanjabi; Richard A Flavell
Journal:  J Immunol       Date:  2013-05-17       Impact factor: 5.422

10.  Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid.

Authors:  Cheng-Ming Sun; Jason A Hall; Rebecca B Blank; Nicolas Bouladoux; Mohamed Oukka; J Rodrigo Mora; Yasmine Belkaid
Journal:  J Exp Med       Date:  2007-07-09       Impact factor: 14.307

View more
  98 in total

1.  TCR signaling intensity controls CD8+ T cell responsiveness to TGF-β.

Authors:  Vidhyalakshmi Arumugam; Theresa Bluemn; Erin Wesley; Amanda M Schmidt; Taku Kambayashi; Subramaniam Malarkannan; Matthew J Riese
Journal:  J Leukoc Biol       Date:  2015-07-07       Impact factor: 4.962

2.  Elevated transforming growth factor β1 in plasma of primary open-angle glaucoma patients.

Authors:  John Kuchtey; Jessica Kunkel; L Goodwin Burgess; Megan B Parks; Milam A Brantley; Rachel W Kuchtey
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-07-24       Impact factor: 4.799

Review 3.  The role of transforming growth factor (TGF)-β in the infarcted myocardium.

Authors:  Nikolaos G Frangogiannis
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

Review 4.  Helper T cell plasticity: impact of extrinsic and intrinsic signals on transcriptomes and epigenomes.

Authors:  Michael Bonelli; Han-Yu Shih; Kiyoshi Hirahara; Kentner Singelton; Arian Laurence; Amanda Poholek; Tim Hand; Yohei Mikami; Golnaz Vahedi; Yuka Kanno; John J O'Shea
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

5.  Keratinocyte-derived TGFβ is not required to maintain skin immune homeostasis.

Authors:  Yi Yang; Yukari Zenke; Toshiro Hirai; Daniel H Kaplan
Journal:  J Dermatol Sci       Date:  2019-05-07       Impact factor: 4.563

6.  Foxp3-independent mechanism by which TGF-β controls peripheral T cell tolerance.

Authors:  Soyoung A Oh; Ming Liu; Briana G Nixon; Davina Kang; Ahmed Toure; Michael Bivona; Ming O Li
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-21       Impact factor: 11.205

Review 7.  Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells.

Authors:  Annie A Wu; Virginia Drake; Huai-Shiuan Huang; ShihChi Chiu; Lei Zheng
Journal:  Oncoimmunology       Date:  2015-04-01       Impact factor: 8.110

Review 8.  Tecemotide: an antigen-specific cancer immunotherapy.

Authors:  Gregory T Wurz; Chiao-Jung Kao; Michael Wolf; Michael W DeGregorio
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

9.  Immune Suppression Mediated by Myeloid and Lymphoid Derived Immune Cells in the Tumor Microenvironment Facilitates Progression of Thyroid Cancers Driven by HrasG12V and Pten Loss.

Authors:  Lee Ann Jolly; Nicole Massoll; Aime T Franco
Journal:  J Clin Cell Immunol       Date:  2016-09-16

Review 10.  Therapeutic cancer vaccines.

Authors:  Cornelis J M Melief; Thorbald van Hall; Ramon Arens; Ferry Ossendorp; Sjoerd H van der Burg
Journal:  J Clin Invest       Date:  2015-07-27       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.